Nektar Therapeutics reported $4.97M in Cost of Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Agios Pharmaceuticals AGIO:US USD 517K 82K
ALKERMES ALKS:US USD 50.62M 7.74M
Amgen AMGN:US USD 1.59B 78M
Astrazeneca AZN:US USD 2.12B 214M
Baxter International BAX:US USD 2.63B 337M
Biocryst Pharmaceuticals BCRX:US USD 3.61M 3.37M
Biogen BIIB:US USD 469.5M 14.5M
Bristol Myers Squibb BMY:US USD 2.35B 324M
Cara Therapeutics CARA:US USD 3.06M 3.06M
Dr.Reddys Laboratories DRRD:IN INR 18.47B 643M
Eisai 4523:JP JPY 45.13B 2.27B
Eli Lilly And LLY:US USD 1.58B 148.6M
Esperion Therapeutics ESPR:US USD 6.51M 2.67M
Exelixis EXEL:US USD 15.3M 1.82M
Gilead Sciences GILD:US USD 1.4B 47M
GlaxoSmithKline GSK:LN GBP 2.39B 250M
Halozyme Therapeutics HALO:US USD 47.32M 13.38M
IONIS PHARMACEUT IONS:US USD 1.52M 3.23M
Karyopharm Therapeutics KPTI:US USD 980K 41K
MacroGenics MGNX:US USD 3.14M 741K
Merk MRK:US USD 3.43B 715M
Nektar Therapeutics NKTR:US USD 4.97M 143K
Neurocrine Biosciences NBIX:US USD 6.1M 1.3M
Novartis NOVN:VX USD 3.66B 92M
Pfizer PFE:US USD 6.09B 2.58B
Roche Holding ROG:VX 9.56B 717M
Sarepta Therapeutics SRPT:US USD 39.95M 2.16M
Seattle Genetics SGEN:US USD 108.12M 2.02M
Takeda 4502:JP JPY 305.44B 12.56B
Teva Pharmaceutical TEVA:IT USD 1.88B 73M
YTE INCY:US USD 49.28M 4.05M